2m 2m 2m 2m 2m 2m 2m
IMMUNOME (IMNM)
NASDAQ
$24.68+$0.010 (+0.04%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.8BMarket Cap
- 167.86%1-Year Change
- BiotechnologyIndustry
IMMUNOME (IMNM)
$24.68+$0.010 (+0.04%)
IMNM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.67 | ||
Change | -$0.30 (-1.20%) | ||
Open | $25.32 | ||
High | $25.73 | ||
Low | $24.60 | ||
Previous Close | $24.97 | ||
Volume | 692,563 | ||
30-Day Average Volume | 1,062,825 | ||
1-Week Change | -7.81% | ||
1-Month Change | -6.02% | ||
1-Year Change | 167.86% | ||
3-Year Change | 215.88% | ||
5-Year Change | 32.28% | ||
Fundamentals | |||
Shares Outstanding | 113.6M | ||
Total Assets | $565.4M | ||
Market Cap | $2.8B | ||
Enterprise Value | $2.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$73.1M | ||
Free Cash Flow | -$63.9M | ||
EBIT | -$73.1M | ||
EBITDA | -$72.2M | ||
Net Working Capital | $502.7M | ||
EPS | -$0.65 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -38 | ||
PEG | 1 | ||
Price/Free Cash Flow | -44 | ||
Price/Operating Cash Flow | -45 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 1000 | ||
Last Split Date | 12/19/2007 | ||
Earnings & Revenue